A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer Meeting Abstract


Authors: Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
Abstract Title: A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 3 Suppl.
Meeting Dates: 2014 Jan 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-01-01
Language: English
ACCESSION: WOS:000333682100059
PROVIDER: wos
Notes: Meeting Abstract -- Gastrointestinal Cancers Symposium -- JAN 16-18, 2014 -- San Francisco, CA -- S -- Source: Wos
MSK Authors
  1. David Solit
    431 Solit
  2. Geoffrey Yuyat Ku
    86 Ku
  3. Marinela Capanu
    206 Capanu
  4. Yelena Yuriy Janjigian
    145 Janjigian
  5. Karen T Brown
    161 Brown
  6. David H Ilson
    269 Ilson
  7. Michael Forman Berger
    380 Berger
  8. Mark Schattner
    102 Schattner
  9. Efsevia Vakiani
    162 Vakiani
  10. David P Kelsen
    332 Kelsen
  11. Tooba   Imtiaz
    7 Imtiaz